Nusinersen ThecaFlex DRx clinical trial program update
Biogen informs that two studies evaluating the use of an implantable port and catheter device for the intrathecal delivery of nusinersen (via the ThecaFlex DRx System) are open for enrollment.
SMA Newsroom